09:14 AM EDT, 06/18/2025 (MT Newswires) -- Health care stocks were edging higher premarket Wednesday with the Health Care Select Sector SPDR Fund ( XLV ) and iShares Biotechnology ETF (IBB) slightly advancing recently.

Scholar Rock Holding ( SRRK ) shares were advancing by more than 4% after the company said a phase 2 trial showed that apitegromab combined with tirzepatide achieved a 54.9% preservation of lean mass compared with tirzepatide alone, leading to higher quality weight loss.

Prenetics (PRE) shares were up more than 19% after the company said it has completed the sale of ACT Genomics to Delta Electronics in a deal valued at up to $71.8 million.

Senti Biosciences ( SNTI ) shares were more than 1% higher after the company said the US Food and Drug Administration has granted orphan drug designation for SENTI-202, a drug candidate for relapsed or refractory acute myeloid leukemia.